Cravatex (BOM:509472) Cyclically Adjusted Revenue per Share: ₹2,129.98 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:509472 Cravatex Ltd BOM:509472
59 GF Score
Price ₹344.40
GF Value ₹303.09
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Cravatex Cyclically Adjusted Revenue per Share?

Cravatex BOM:509472 -1.35% 59 Cyclically Adjusted Revenue per Share is ₹2,129.98 as of Mar. 2026. GuruFocus rates BOM:509472 with a GF Score™ of 59/100 and a GF Value™ of ₹303.09 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cravatex's adjusted revenue per share for the three months ended in Mar. 2026 was ₹152.795. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹2,129.98 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cravatex's average Cyclically Adjusted Revenue Growth Rate was -4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-14), Cravatex's current stock price is ₹344.40. Cravatex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹2,129.98. Cravatex's Cyclically Adjusted PS Ratio of today is 0.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cravatex was 0.22. The lowest was 0.14. And the median was 0.18.


Cravatex  (BOM:509472) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cravatex's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=344.40/2129.98
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cravatex was 0.22. The lowest was 0.14. And the median was 0.18.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cravatex Cyclically Adjusted Revenue per Share Related Terms


Cravatex Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cravatex's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cravatex Cyclically Adjusted Revenue per Share Chart

Cravatex Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2,233.51 2,129.98

Cravatex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,233.51 2,205.15 2,196.37 2,161.53 2,129.98

BOM:509472 vs AS, HAS, LTH: Cyclically Adjusted Revenue per Share Comparison

For the Leisure subindustry, Cravatex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cravatex Cyclically Adjusted PS Ratio vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Cravatex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cravatex's Cyclically Adjusted PS Ratio falls into.


BOM:509472
59GF Score
Cravatex Ltd BOM:509472
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cravatex Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cravatex's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=152.795/164.2724*164.2724
=152.795

Current CPI (Mar. 2026) = 164.2724.

Cravatex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201206 219.822 79.567 453.843
201209 213.563 82.244 426.565
201212 184.762 83.774 362.298
201303 231.590 85.687 443.986
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 414.550 111.317 611.761
201812 828.536 115.142 1,182.068
201903 731.597 118.202 1,016.743
201906 619.413 120.880 841.766
201909 939.261 123.175 1,252.646
201912 777.594 126.235 1,011.898
202003 1,009.706 124.705 1,330.073
202006 200.900 127.000 259.860
202009 623.481 130.118 787.138
202012 596.942 130.889 749.192
202103 636.424 131.771 793.401
202106 478.103 134.084 585.745
202109 606.356 135.847 733.233
202112 617.004 138.161 733.615
202203 597.508 138.822 707.051
202206 628.481 142.347 725.283
202209 659.528 144.661 748.938
202212 337.058 145.763 379.859
202303 322.778 146.865 361.037
202306 219.032 150.280 239.426
202309 222.332 151.492 241.089
202312 146.687 152.924 157.572
202403 196.129 153.035 210.531
202406 99.637 155.789 105.063
202409 213.071 157.882 221.695
202412 125.652 158.323 130.374
202503 234.306 157.552 244.301
202506 89.466 159.755 91.996
202509 199.014 162.289 201.446
202512 142.208 163.281 143.072
202603 152.795 164.272 152.795

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹2,129.98 mean?
Cravatex (BOM:509472) has a Cyclically Adjusted Revenue per Share of ₹2,129.98 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cravatex and its competitors.
Is Cravatex's Cyclically Adjusted Revenue per Share too high?
Cravatex's current Cyclically Adjusted Revenue per Share is ₹2,129.98. Overall, Cravatex has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cravatex's Cyclically Adjusted Revenue per Share compare to AS and HAS?
Cravatex's Cyclically Adjusted Revenue per Share of ₹2,129.98 can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Travel & Leisure company?
A good Cyclically Adjusted Revenue per Share depends on the Travel & Leisure industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cravatex and its competitors. Cravatex's current Cyclically Adjusted Revenue per Share is ₹2,129.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cravatex stock overvalued right now?
Based on GuruFocus' analysis, Cravatex (BOM:509472) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹303.09, compared to a current price of ₹344.40 — trading 13.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹2,129.98. Cravatex's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cravatex (BOM:509472), the current Cyclically Adjusted Revenue per Share is ₹2,129.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cravatex (BOM:509472) Overvalued in 2026?

Based on GuruFocus' analysis, Cravatex stock appears to be overvalued. The current stock price of ₹344.40 is trading 13.6% above its estimated GF Value™ of ₹303.09. GuruFocus considers Cravatex to be Modestly Overvalued.

Key valuation signals for BOM:509472:

  • Cyclically Adjusted Revenue per Share: ₹2,129.98
  • GF Value™: ₹303.09 vs. price of ₹344.40 (13.6% above fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the BOM:509472 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cravatex Business Description

Address 4A Home Street, Charanjit Rai Marg, 1st Floor, Godrej Bhavan, Fort, Mumbai, MH, IND, 400001
Cravatex Ltd is engaged in the trading business of branded sports goods, Retail, Brand Licensing, Distribution, and Sourcing. The company has a business presence across the Indian subcontinent, the United Kingdom, Europe, North Africa, and the Middle East.
59GF Score

Get the complete analysis for BOM:509472

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹344.40
Price
₹303.09
GF Value